The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
E5103 was a study designed to evaluate the efficacy and safety of bevacizumab. It was a negative trial for the end points of invasive disease–free survival and overall survival. The current work examines the tolerability of bevacizumab and other medication exposures with respect to clinical outcomes and patient‐reported outcomes (PROs).
Methods
Adverse events (AEs) collected from the...
Objectives
To better capture the scope of caregiver burden by creating a composite of 3 existing measures that assess different health domains.
Design
Prospective follow‐up study.
Setting
University‐based dementia care management program.
Participants
Caregivers of persons with dementia (PWD) (N=1,091).
Measurements
The composite measure (the Dementia Burden Scale—Caregiver (DBS‐CG)) was...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.